NEW YORK (TheStreet) -- CHANGE IN RATINGS
downgraded at UBS from Buy to Neutral. $16 price target. Estimates also lowered, because of new cost expectations.
upgraded at Deutsche from Hold to Buy. $17 price target. Recent customer announcement should drive meaningful sales and China may soon introduce incentives.
downgraded at JP Morgan. Rating lowered to Neutral from Overweight. Maintains $19 price target. 2010 EPS estimates lowered to $0.89 from $0.93.
downgraded at UBS from Buy to Neutral. $41 price target. Estimates also cut, because of lower net interest margin expectations.
upgraded at Oppenheimer from Perform to Outperform. $70 price target. Company is on track to reach asset sale target with its Syncrude deal.
upgraded at Credit Suisse to Outperform from Neutral due to new insights on the DOE's Gainful Employment stance. Price target jumped to $75 from $55.
upgraded to Credit Suisse to Outperform from Neutral on new proposal from DOE. Price target improved to $135 from $105.
upgraded at Goldman from Neutral to Buy. Company was also added to the Conviction List, based on a $31 price target. Stock has outperformed and the company should benefit from improving hotel trends.
rated new Buy at Jesup & Lamont. $130 price target. Company should post strong sales and earnings later this week and is also likely to repurchase stock in 2010.
downgraded at UBS from Neutral to Sell. $4 price target. Estimates also cut, because of TARP-related capital raises.
downgraded at Deutsche from Buy to Hold. $33.50 price target. Valuation call, as the stock is up 102% since May.
rated new Buy at Canaccord Adams. $40 price target. Stock no longer deserves a conglomerate discount.
initiated at JP Morgan with an Overweight rating and $60 price target. Introduces 2010 EPS estimates of -$2.41.
downgraded at UBS from Neutral to Sell. $5 price target. Company faces earnings headwinds.
downgraded at Goldman from Buy to Neutral. Valuation call, based on a $275 price target.
downgraded at UBS from Neutral to Sell. $6 price target. Company is facing credit and sales headwinds.
rated new Buy at UBS. Company is a leader in open source software and should deliver strong billings and cash flow growth. $35 price target.
downgraded at UBS from Neutral to Sell. $12 price target. Estimates also lowered, given lower net interest margin expectations.
upgraded at Leerink from Market Perform to Outperform. Expect earnings upside potential, as minimum losses are already priced into the stock.
STOCK COMMENTS / EPS CHANGES
estimates boosted at UBS through 2011. Acquisition of DVN assets should add to earnings. Buy rating and $130 price target.
numbers raised at FBR. Shares of BEN now seen reaching $121. Estimates also increased, given higher asset levels at the end of the quarter. Market Perform rating.
cut from Conviction Buy List at Goldman. Shares of CAKE now seen reaching $31. Estimates also upped, because of the company's higher expected sales growth. Buy rating, but the stock was also removed from the Conviction List.
numbers increased at Morgan Stanley. Shares of DG now seen reaching $32. Estimates also boosted, as margins could continue to expand. Overweight rating.
estimate, target increased at Goldman. EBAY estimates were raised through 2012. Company is seeing more successful US sales and payment volume growth. Neutral rating and new $27.50 price target.
Jones Apparel Group
target, estimates raised at Barclays. JNY price target lifted to $24 from $22 on improving trends in retail segment. 2010 and 2011 EPS estimates improved to $1.35 and $1.60, respectively. Maintain Equal Weight rating.
price target higher at Barclays. OI price target jumped to $32 from $26 on improved visibility. 2010 and 2011 EPS estimates held at $3.25 and $4.15, respectively. Underweight rating.
Polo Ralph Lauren
target, estimates boosted at Barclays. RL price target surged to $100 from $85 as the company has seen a rebound in its wholesale business. 2010 and 2011 EPS estimates increased to $4.30 and $4.85, respectively. Equal Weight rating.
estimates, target boosted at UBS. TLAB estimates were increased through 2011. Company should benefit from positive end-market demand trends. Neutral rating and new $8.50 price target.
estimates, target raised at Goldman. VMW estimates were increased through 2012. Company is positioned well, following strong market checks. Neutral rating and new $60 price target.
This article was written by a staff member of TheStreet.com.